Studies on effectiveness of PTT on 3D tumor model under microfluidic conditions using aptamer-modified nanoshells.
3D cell culture
Hollow gold nanoshells
Lab-on-a-chip
Microfluidic system
Photothermal therapy
Spheroids
Journal
Biosensors & bioelectronics
ISSN: 1873-4235
Titre abrégé: Biosens Bioelectron
Pays: England
ID NLM: 9001289
Informations de publication
Date de publication:
01 Feb 2019
01 Feb 2019
Historique:
received:
07
09
2018
revised:
19
10
2018
accepted:
31
10
2018
pubmed:
14
11
2018
medline:
19
4
2019
entrez:
14
11
2018
Statut:
ppublish
Résumé
Herein, we present the research focused on the synthesis and application of aptamer-modified gold nanoshells for photothermal therapy (PTT). NIR-absorbing hollow gold nanoshells were synthetized and conjugated with anti-MUC1 aptamer (HGNs@anti-MUC1). MUC1 (Mucin 1) is a transmembrane glycoprotein, which is overexpressed in a variety of epithelial cancers (eg. breast, lung, pancreatic). In order to evaluate the efficiency of PTT with HGNs@anti-MUC1 we used 3D cell culture model - multicellular spheroids. The selected cell culture model is considered as the best in vitro model for cancer research (similar morphology, metabolite and oxygen gradients, cellular interactions and cell growth kinetics in the spheroids are similar to the early stage of a nonvascular tumor). We conducted our research on human normal (MRC-5, MCF-10A) and tumor (A549, MCF-7) cell lines using a microfluidic system. Aptamer-modified nanoparticles were accumulated selectively in tumor cells (A549, MCF-7) and this fact contributed to the reduction of tumor spheroids viability and size. It should be underlined, that it is the first example of photothermal therapy carried out in a microsystem on multicellular spheroids.
Identifiants
pubmed: 30423478
pii: S0956-5663(18)30887-X
doi: 10.1016/j.bios.2018.10.069
pii:
doi:
Substances chimiques
Aptamers, Peptide
0
MUC1 protein, human
0
Mucin-1
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
214-221Informations de copyright
Copyright © 2018 Elsevier B.V. All rights reserved.